Notification letter and request form
Filed with HKEX · Stock code 690 · · 2 pages · English and Chinese
The English and Chinese versions of the Company’s Current Corporate Communications are available on the Company’s website at www.uni-bioscience.com and the website of The Stock Exchange of Hong Kong Limited (the “Stock Exchange”) at www.hkexnews.hk respectively (the “Website Version”). The Company strongly recommends you to access the Website Version of Current Corporate Communication. If you have
Uni Bio Science Group, Ltd. on 6ix
Earlier from Uni Bio Science
- Interim Report 2026
- Uni Bio Science Secures Approval for Recombinant Collagen Class II Medical Device and Launches 肌顏態®: Pioneering Entry into the High Growth Medical Aesthetics Market
- Uni Bio Science Announces 2022 Annual Results,Record High Turnover of HK$440.3 Million and HK$38.5 Million Profit Achieved Expanding Portfolio with New Drug Innovations and Strategic R&D Partnerships
- Interim Report 2022
- Uni Bio Science opens Hong Kong research centre,Future R&D focus in four major businesses
Later from Uni Bio Science
- Notification letter and reply form
- Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
Follow Uni Bio Science into a list and get an email when it puts out news.
Follow Uni Bio Science